Nan Liu Enterprise Co., Ltd. (6504.TW)
TWD 53.7
(-0.56%)
TWD 53.7
(-0.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 798.8 Million TWD | -10.95% |
| 2022 | 749.05 Million TWD | 0.04% |
| 2021 | 773.5 Million TWD | -69.0% |
| 2020 | 2.43 Billion TWD | 130.63% |
| 2019 | 1.07 Billion TWD | -8.84% |
| 2018 | 1.18 Billion TWD | 14.44% |
| 2017 | 1.03 Billion TWD | -4.72% |
| 2016 | 1.08 Billion TWD | 1.83% |
| 2015 | 1.06 Billion TWD | 20.42% |
| 2014 | 888.31 Million TWD | 21.42% |
| 2013 | 731.58 Million TWD | 38.57% |
| 2012 | 507.34 Million TWD | 30.67% |
| 2011 | 404.15 Million TWD | 42.39% |
| 2010 | 282.84 Million TWD | -3.92% |
| 2009 | 291.36 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 174.9 Million TWD | 90.59% |
| 2024 Q2 | 160.4 Million TWD | -14.85% |
| 2023 Q4 | 190.66 Million TWD | -12.41% |
| 2023 Q1 | 189.65 Million TWD | 12.35% |
| 2023 Q2 | 282.73 Million TWD | 49.08% |
| 2023 FY | - TWD | -10.95% |
| 2023 Q3 | 217.66 Million TWD | -23.01% |
| 2022 Q2 | 239.88 Million TWD | 59.67% |
| 2022 Q1 | 150.24 Million TWD | -3.04% |
| 2022 FY | - TWD | 0.04% |
| 2022 Q4 | 168.8 Million TWD | -21.67% |
| 2022 Q3 | 215.52 Million TWD | -10.16% |
| 2021 Q3 | 166.66 Million TWD | -8.61% |
| 2021 FY | - TWD | -69.0% |
| 2021 Q2 | 182.35 Million TWD | -32.5% |
| 2021 Q1 | 270.15 Million TWD | -62.58% |
| 2021 Q4 | 154.95 Million TWD | -7.03% |
| 2020 Q4 | 721.96 Million TWD | -8.35% |
| 2020 Q2 | 666.55 Million TWD | 107.88% |
| 2020 Q3 | 787.77 Million TWD | 18.19% |
| 2020 Q1 | 320.64 Million TWD | 11.42% |
| 2020 FY | - TWD | 130.63% |
| 2019 Q3 | 320.82 Million TWD | 28.72% |
| 2019 Q1 | 224.26 Million TWD | -26.66% |
| 2019 FY | - TWD | -8.84% |
| 2019 Q4 | 287.77 Million TWD | -10.3% |
| 2019 Q2 | 249.24 Million TWD | 11.14% |
| 2018 Q1 | 250.85 Million TWD | -12.37% |
| 2018 FY | - TWD | 14.44% |
| 2018 Q4 | 305.77 Million TWD | -0.23% |
| 2018 Q3 | 306.49 Million TWD | -5.56% |
| 2018 Q2 | 324.51 Million TWD | 29.37% |
| 2017 Q3 | 260.86 Million TWD | 5.93% |
| 2017 FY | - TWD | -4.72% |
| 2017 Q2 | 246.26 Million TWD | 0.06% |
| 2017 Q1 | 246.11 Million TWD | -20.04% |
| 2017 Q4 | 286.27 Million TWD | 9.74% |
| 2016 Q4 | 307.79 Million TWD | 16.47% |
| 2016 Q3 | 264.27 Million TWD | -4.7% |
| 2016 Q2 | 277.31 Million TWD | 16.18% |
| 2016 Q1 | 238.68 Million TWD | -5.52% |
| 2016 FY | - TWD | 1.83% |
| 2015 Q1 | 265.74 Million TWD | 16.11% |
| 2015 Q3 | 258.58 Million TWD | -11.66% |
| 2015 Q4 | 252.62 Million TWD | -2.31% |
| 2015 FY | - TWD | 20.42% |
| 2015 Q2 | 292.7 Million TWD | 10.15% |
| 2014 Q4 | 228.87 Million TWD | 15.16% |
| 2014 FY | - TWD | 21.42% |
| 2014 Q3 | 198.73 Million TWD | -14.11% |
| 2014 Q2 | 231.38 Million TWD | 0.9% |
| 2014 Q1 | 229.32 Million TWD | 1.86% |
| 2013 Q4 | 225.14 Million TWD | 34.64% |
| 2013 FY | - TWD | 38.57% |
| 2013 Q1 | 156.84 Million TWD | -38.14% |
| 2013 Q2 | 182.37 Million TWD | 16.28% |
| 2013 Q3 | 167.22 Million TWD | -8.31% |
| 2012 FY | - TWD | 30.67% |
| 2012 Q1 | 97.41 Million TWD | -58.94% |
| 2012 Q2 | 150.71 Million TWD | 54.72% |
| 2012 Q3 | 64.99 Million TWD | -56.88% |
| 2012 Q4 | 253.54 Million TWD | 290.12% |
| 2011 Q3 | 42.88 Million TWD | 0.0% |
| 2011 Q2 | - TWD | 0.0% |
| 2011 Q4 | 237.25 Million TWD | 453.27% |
| 2011 FY | - TWD | 42.39% |
| 2010 FY | - TWD | -3.92% |
| 2010 Q4 | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Farcent Enterprise Co.,Ltd | 355.04 Million TWD | -124.984% |
| Mao Bao Inc. | 9.01 Million TWD | -8760.81% |
| Taiyen Biotech Co., Ltd. | 518.26 Million TWD | -54.13% |
| Sanitar Co., Ltd. | 401.77 Million TWD | -98.817% |
| Chlitina Holding Limited | 1.96 Billion TWD | 59.427% |
| Jourdeness Group Limited | 802.68 Million TWD | 0.484% |
| Luo Lih-Fen Holding Co., Ltd. | 120.7 Million TWD | -561.78% |
| San Neng Group Holdings Co., Ltd. | 336.41 Million TWD | -137.446% |
| Yuen Foong Yu Consumer Products Co., Ltd. | 1.67 Billion TWD | 52.197% |
| KNH Enterprise Co., Ltd. | 1.41 Billion TWD | 43.569% |